Specifications Manual for Joint Commission National Quality Measures (v2020A)
Posted: August 1, 2019
Discharges 01-01-20 (1Q20) through 6-30-20 (2Q20)
Home » VTE Prophylaxis Status

Release Notes:
Data Element
Version 2020A

Name:VTE Prophylaxis Status
Collected For: VTE-6
Definition:Documentation of VTE prophylaxis (mechanical or pharmacologic) administration between the hospital arrival date and the day before the VTE Diagnostic Test order date.
Question:Was VTE prophylaxis administered between the arrival date and the day before the VTE Diagnostic Test order date?
Allowable Values:

Y (Yes)      There is documentation that VTE prophylaxis was administered between the day of arrival and the day before the VTE Diagnostic Test order date.

N (No)      There is no documentation that VTE prophylaxis was administered between the day of arrival and the day before the VTE Diagnostic Test order date or unable to determine from medical record documentation.
Notes for Abstraction:
  • If ANY VTE prophylaxis was administered within the specified time frame above, select “Yes.”
  • If more than one acceptable VTE Diagnostic Test was ordered to rule out VTE and both confirmed VTE, select the earliest diagnostic test ordered that confirmed VTE to determine if the patient received VTE prophylaxis.
    Patient arrived on 11/1/20XX. A venous Doppler of lower extremities was ordered 11/4/20xx and confirmed a DVT of the right lower extremity. In addition, a CT scan with contrast was ordered on 11/5/20xx and confirmed a PE. Determine if any prophylaxis was administered any time between the hospital arrival date of 11/1/20XX and 11/3/20xx. If no prophylaxis was given, select “No.”
  • If the VTE Diagnostic Test was ordered the day of or the day after the arrival date, select “Yes.”
  • If the patient was admitted and had surgery on day of or day after hospital admission or ICU admission and VTE prophylaxis was administered before the VTE Diagnostic Test was ordered, select “Yes.”
    MVA arrives 10/09. Lovenox ordered and held for surgery 10/10. Lovenox administered 10/11 at 0140. CTA abdomen ordered 10/11 2100.
  • If the record contains questionable information regarding the administration of VTE prophylaxis the day before the VTE Diagnostic Test was ordered, select “No.”
  • Application of mechanical prophylaxis may be documented by any personnel.
    Nursing assistant documentation of IPC application during the allowable time frame is acceptable.
  • Evaluate prophylaxis with documentation of administration only.
    The only documentation of prophylaxis is in the physician progress notes under assessment/Plan: “DVT prophylaxis – IPC,” select “No” because there is no documentation of administration.
  • If one pharmacological medication is ordered and another medication is substituted (such as per pharmacy formulary substitution or protocol), select “Yes” if the substitution medication was administered.
    Note: No copy of the formulary or protocol is required in the medical record.
    Lovenox is ordered but not administered, and is substituted with Arixtra, which is administered. Select “Yes.”
  • Aspirin is only acceptable as VTE prophylaxis in total hip replacement and total knee replacement surgery.
Suggested Data Sources:
  • Circulator notes
  • Emergency department record
  • Graphic/flow sheets
  • Medication administration record
  • Nursing notes
  • Operative notes
  • Physician notes
  • Preoperative nursing notes
  • Progress notes
  • Radiology reports
Additional Notes:
Guidelines for Abstraction:
Inclusion Exclusion

A list of the ONLY acceptable diagnostic tests is found in the data element VTE Diagnostic Test.

Refer to Appendix H, Table 2.1 VTE Prophylaxis Inclusion Table.

VTE Prophylaxis Status
CPT® only copyright 2019 American Medical Association. All rights reserved.
Specifications Manual for Joint Commission National Quality Measures (v2020A)
Discharges 01-01-20 (1Q20) through 6-30-20 (2Q20)


CPT® only copyright 2019 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.